Pathology and regulation for research in the UK: an overview
作者: Owen John DriskellJessica L. LeeKarin A. OienAndy HallClare Verrill
作者单位: 1Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent,, Staffordshire, UK
2Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire, UK
3National Institute for Health Research Clinical Research Network West Midlands, NIHR CRN, Albrighton, Shropshire, UK
4Strategy and Initiatives, National Cancer Research Institute, London, UK
5Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
6Newcastle University, Newcastle, UK
7Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
刊名: F1000Research, 2019, Vol.8
来源数据库: F1000 Research Ltd
DOI: 10.12688/f1000research.19732.2
关键词: Research regulationResearch governanceMHRAGCPHTAQuality ManagementClinical TrialCTIMP
原始语种摘要: The input of pathologists is essential for the conduct of many forms of research, including clinical trials. As the custodians of patient samples, pathology departments have a duty to ensure compliance with the relevant regulations, standards and guidelines to ensure the ethical and effective use for their intended investigational analysis, including when patients are participating in a research study. The results of research studies have impacts beyond the research study itself as they may inform changes in policy and practice or support the licensing of medicines and devices. Compliance with regulations and standards provides public assurance that the rights, safety and wellbeing of research participants are protected, that the data have been collected and processed to ensure their...
全文获取路径: F1000 Research Ltd 

  • research 
  • regulation 
  • standards 规程
  • ensure 担保
  • barrier 堡坝
  • governance 统治方式
  • their 他们的
  • safety 安全
  • purpose 目的
  • guidance 制导